Change over period: —
NSE · ARISTO
Aristo Bio-Tech & Lifescience Ltd
Operates in biotechnology and life sciences segment. Manufactures bio-based healthcare and agri products. Revenue comes from product sales. Focuses on research-backed formulations. Serves healthcare and agricultural markets. Operates innovation-led manufacturing model.
The short version. Promoter holding was 73.42% in Sep 2026, up 0.05 points over 8 quarters.
1 · The price
How has the stock traded?
4 · The owners
Who holds it, and are they adding?
Up 0.05 pts over 8 quarters.
+0 versus the previous month.
Shareholding pattern (%)
Quarter by quarter
| Mar 2023 | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 | Sep 2026 | Change | |
|---|---|---|---|---|---|---|---|---|---|
| Promoter | 73.37 | 73.37 | 73.37 | 73.37 | 73.42 | 73.42 | 73.42 | 73.42 | +0.05 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Public | 26.62 | 26.63 | 26.63 | 26.63 | 26.58 | 26.58 | 26.58 | 26.58 | -0.04 |
Mutual fund holdings · Oct 2026
0 schemes hold this stock
0 the month before.
5 · The model view
What does our factor model say?
Factor scores, model flags and screen results for Aristo Bio-Tech & Lifescience Ltd are part of the Wright portfolio review.
Run your free portfolio reviewWatchouts
What to review
Model flags are shown inside the portfolio review, alongside your other holdings.
Related stocks
Other Fertilizers & Agrochemicals stocks
Quick answers
Common questions about Aristo Bio-Tech & Lifescience Ltd
What is the Aristo Bio-Tech & Lifescience Ltd share price?
Aristo Bio-Tech & Lifescience Ltd (ARISTO) last closed at ₹126.95, up 0.0% on the day.
What is the market cap of Aristo Bio-Tech & Lifescience Ltd?
Aristo Bio-Tech & Lifescience Ltd has a market capitalisation of about ₹86 crore. Its price-to-earnings ratio is 11.7.
How are Aristo Bio-Tech & Lifescience Ltd's latest results?
Promoter holding was 73.42% in Sep 2026, up 0.05 points over 8 quarters.
Who owns Aristo Bio-Tech & Lifescience Ltd?
As of Sep 2026, shareholding was: Promoter 73.42%, Public 26.58%.
How many mutual funds hold Aristo Bio-Tech & Lifescience Ltd?
0 mutual fund schemes held Aristo Bio-Tech & Lifescience Ltd in October 2026. That compares with 0 the month before.
Corporate actions
Recent dividends, bonuses and splits
- 01 Sep 2025 · Dividend - Rs. 0.5
- 13 Sep 2024 · Dividend - Rs. 0.4
- 15 Sep 2023 · Dividend - Rs. 0.25
Research data on this page is provided under Wright Research's SEBI Research Analyst registration. The Terms & Conditions of our Research Analyst services apply.